The manufacturing operations of Emcure Pharmaceuticals are spread across 13 manufacturing facilities in India. Emcure is vertically integrated, with production facilities for APIs, biologics and formulations, enabling greater control over product quality, supply chain and operating costs.
Emcure is committed to providing high quality products to customers and to meet this commitment, we have implemented current good manufacturing practices across our manufacturing sites. This enables us to maintain consistent quality, efficiency and product safety.
Our current facilities have the capability to manufacture various dosage forms:
Approvals received :
Health Canada, NIPN Hungary, TGA Australia, MOH Russia, cGMP India, GCC, ANVISA Brazil, SAHPRA South Africa
Approvals received :
cGMP India
Approvals received :
MCAZ Zimbabwe, PPB Kenya, TFDA Tanzania, NDA Uganda, NMRA Sri Lanka, MOH Russia, cGMP India
Approvals received :
USFDA, EDQM (Europe), cGMP India
Approvals received :
USFDA, cGMP India, MCAZ Zimbabwe
Approvals received :
USFDA, Health Canada, NIPN Hungary, cGMP India
Approvals received :
USFDA, cGMP India
Approvals received :
MCAZ Zimbabwe, PPB Kenya, cGMP India
Approvals received :
cGMP India, NDA Uganda, PPB Kenya, Ethiopian FDA
Approvals received :
cGMP India, NDA Uganda, PPB Kenya, Ethiopian FDA
Approvals received :
State FDA, NDA Uganda, PPB Kenya, Ethiopian FDA
Approvals received :
Health Canada, NIPN Hungary, ANVISA Brazil
Approvals received :
cGMP India, Malta Medicines Authority (Malta), PPB Kenya